Immuron Limited announced the appointment of Gary S. Jacob as Chief Executive Officer. Dr. Jacob is the former Chairman, President and Chief Executive Officer of Synergy Pharmaceuticals Inc. Dr. Jacob's 30 years of extensive experience in the pharmaceutical and biotechnology industries covers multiple disciplines, including research and development, operations, business development, capital financing activities and senior management expertise. He is the co-founder and founding CEO of Synergy Pharmaceuticals, which went public in 2008, and is the co-inventor of TRULANCE (plecanatide).